Retifanlimab is a monoclonal antibody targeting the programmed cell death protein 1 (PD-1) receptor, designed to modulate immune responses in tumor microenvironments. This antibody is particularly utilized in the study of gastroesophageal adenocarcinoma (GEA), providing a valuable tool for researchers investigating the therapeutic potential of PD-1 inhibition in this cancer type.
Retifanlimab is a monoclonal antibody targeting the programmed cell death protein 1 (PD-1) receptor, designed to modulate immune responses in tumor microenvironments. This antibody is particularly utilized in the study of gastroesophageal adenocarcinoma (GEA), providing a valuable tool for researchers investigating the therapeutic potential of PD-1 inhibition in this cancer type.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
